No Data
No Data
Guangdong Marubi Biotechnology (SHSE:603983) Could Be Struggling To Allocate Capital
Founder Securities: Comprehensive policy efforts, focus on pro-cyclical sectors
Main theme of beauty and skincare: Policies are fully implemented, and the beauty and skincare sector is expected to benefit first.
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) 27% Jump Shows Its Popularity With Investors
Guosen brokerage September strategy and midterm summary: The overall performance of the industry is flat, focusing on the direction of structural prosperity.
Since 2024, consumer overall continues the trend of low-level recovery.
Guangdong Marubi Biotechnology (603983.SH) plans to jointly increase capital by 60 million yuan with affiliated party Wang Kaihui to Qingdao Maoda.
Guangdong Marubi Biotechnology (603983.SH) announced that the company plans to engage in private equity investment partnership with affiliated party Wang Kaihui in Qingdao Maoda.
Dongxing Securities: International beauty group's performance is slightly weak, high-quality domestic brands embrace development opportunities.
The consumer cosmetics market in our country is still relatively weak, but with internal cultivation and external environment optimization, it is the right time for high-quality domestic cosmetic brands to rise.
No Data
No Data